Enfusion Elevates Iris Xinwei Wang to Chief Strategy Officer and Lotte Tønsberg to Head of EMEA Sales and Executive Director, EMEA

Cloud-based SaaS Provider Continues Bolstering Executive Leadership Team Globally NEW YORK & LONDON & HONG…

Oceaneering’s Integrity Management and Digital Solutions Segment Announces Fourth Quarter 2021 Contracts Exceeding $80 Million

HOUSTON--(BUSINESS WIRE)--Oceaneering International, Inc. (NYSE:OII) announces that it has been awarded multiple contracts for its…

Venti Technologies Appoints Renowned Autonomous Vehicle Executives to Company Leadership: James Fu and Demian Chong to Help Scale Company’s Autonomous Logistics Business

Pioneers in self-driving technology including globally operating autonomous fleets BOSTON--(BUSINESS WIRE)--Venti Technologies, the leader in…

Zai Lab Announces NDA Acceptance of Margetuximab for Patients with Pretreated Metastatic HER2-Positive Breast Cancer in China by the NMPA

SHANGHAI and SAN FRANCISCO and CAMBRIDGE, Mass., Jan. 06, 2022 (GLOBE NEWSWIRE) -- Zai Lab…

Tier-1 Mobile Network Carrier in Japan Expanding Their 4G Cellular Network with Gilat’s Backhaul over Satellite

Gilat receives order for additional VSATs to enable the operator's 4G/LTE network growth PETAH TIKVA,…

BeiGene to Present at the J.P. Morgan 40th Annual Healthcare Conference

CAMBRIDGE, Mass. & BEIJING--(BUSINESS WIRE)--$bgne #JPMconference--BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global…

Allay Therapeutics Establishes Corporate Headquarters in the Bay Area and Expands Base of Operations in Singapore

MENLO PARK, Calif.--(BUSINESS WIRE)--Allay Therapeutics, a clinical-stage biotechnology company pioneering ultra-sustained analgesic products to transform…

Get the actionable gaming tips and tricks to ace every game you play

Why do people love playing games? Do you love playing games with your friends and…

Hang Lung Wins String of Awards for its Environmental, Social and Governance Achievements

HONG KONG SAR - Media OutReach - 6 January 2022 - Hang Lung Group Limited (Stock Code: 00010)…

China NMPA Approves Tislelizumab as Second- or Third-Line Treatment for Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Tislelizumab is now approved in six indications in China This marks tislelizumab’s third approved lung…